Skip to main content

Agilent Closes Acquisition of Lab Automation Firm Velocity11

NEW YORK (GenomeWeb News) – Agilent Technologies said last week that it has completed the acquisition of Velocity11, a developer of automated liquid handling and laboratory robotics for the life science market.
 
Financial details of the transaction were not disclosed.
 
Agilent announced its plan to purchase the privately firm last month.
 
The company said that it expects the acquisition to give it “more comprehensive suite of workflow solutions” for the pharmaceutical, biotech, and academic research markets.
 
Agilent said that “substantially all” of Velocity11's 150 employees have joined Agilent.
 
Velocity11 is based in Menlo Park, Calif., and has a second office in Melbourn, UK.
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.